Avadel Pharmaceuticals | 4:持股变动声明-董事 Palczuk Linda
Avadel Pharmaceuticals | 4:持股变动声明-高管 MCHUGH THOMAS S
Avadel Pharmaceuticals | 4:持股变动声明-高管 MCHUGH THOMAS S
Avadel Pharmaceuticals | 4:持股变动声明-高管 Divis Gregory J
Avadel Pharmaceuticals | 4:持股变动声明-董事 Glass Geoffrey Michael
Avadel Pharmaceuticals | 4:持股变动声明-董事 Palczuk Linda
Avadel Pharmaceuticals | 8-K:重大事件
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(13.8%),Janus Henderson Biotech Innovation Master Fund Ltd(5.0%)
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(0%),Roderick Wong, M.D.(0%)
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Polar Capital Holdings Plc(4.99%),Polar Capital LLP(4.99%)
Avadel Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cowen and Company, LLC(0%),Cowen Financial Products LLC(0%)
Avadel Pharmaceuticals | 10-Q:2024财年三季报
Avadel Pharmaceuticals | 8-K:Avadel Pharmicals提供公司最新情况并报告2024年第三季度财务业绩
Avadel Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.5%)
Avadel Pharmaceuticals | 8-K:重大事件
Avadel Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.5%)
Avadel Pharmaceuticals | 8-K:重大事件
Avadel Pharmaceuticals | 4:持股变动声明-董事 Palczuk Linda
Avadel Pharmaceuticals | 4:持股变动声明-董事 Glass Geoffrey Michael
Avadel Pharmaceuticals | 8-K:重大事件
暂无数据